...
首页> 外文期刊>Molecular biology reports >Soluble overexpression and purification of bioactive human CCL2 in E-coli by maltose-binding protein
【24h】

Soluble overexpression and purification of bioactive human CCL2 in E-coli by maltose-binding protein

机译:麦芽糖结合蛋白在大肠杆菌中可溶性过表达和纯化生物活性人CCL2

获取原文
获取原文并翻译 | 示例
           

摘要

Human chemokine (C-C motif) ligand 2 (hCCL2) is a small cytokine in the CC chemokine family that attracts monocytes, memory T lymphocytes, and natural killer cells to the site of tissue injury- or infection-induced inflammation. hCCL2 has been implicated in the pathogeneses of diseases characterized by monocytic infiltrates, including psoriasis, rheumatoid arthritis, atherosclerosis, multiple sclerosis, and insulin-resistant diabetes. The prokaryotic overexpression of hCCL2 has been investigated previously in an attempt to develop biomedical applications for this factor, but this has been hampered by protein misfolding and aggregation into inclusion bodies. In our present study, we screened 7 protein tags-Trx, GST, MBP, NusA, His8, PDI, and PDIb'a'aEuro"for their ability to allow the soluble overexpression of hCCL2. Three tags-MBP, His8, and PDI-solubilized more than half of the expressed hCCL2 fusion proteins. Lowering the expression temperature to 18 A degrees C significantly further improved the solubility of all fusion proteins. MBP was chosen for further study based on its solubility, expression level, ease of purification, and tag size. MBP-CCL2 was purified using conventional chromatography and cleaved using TEV or Factor Xa proteases. Biological activity was assessed using luciferase and cell migration assays. Factor Xa-cleaved hCCL2 was found to be active and TEV-cleaved hCCL2 showed relatively less activity. This is probably because the additional glycine residues present at the N-terminus of hCCL2 following TEV digestion interfere with the binding of hCCL2 to its receptor.
机译:人趋化因子(C-C基序)配体2(hCCL2)是CC趋化因子家族中的一种小细胞因子,可将单核细胞,记忆T淋巴细胞和自然杀伤细胞吸引到组织损伤或感染诱导的炎症部位。 hCCL2与单核细胞浸润有关的疾病的病原体,包括牛皮癣,类风湿性关节炎,动脉粥样硬化,多发性硬化症和胰岛素抵抗性糖尿病。以前已经研究过hCCL2的原核过表达,以尝试开发该因子的生物医学应用,但由于蛋白质错误折叠和聚集成包涵体而受到阻碍。在我们目前的研究中,我们筛选了7种蛋白标签-Trx,GST,MBP,NusA,His8,PDI和PDIb'a'aEuro”,以证明它们能够可溶性表达hCCL2。三种标签-MBP,His8和PDI -溶解了一半以上表达的hCCL2融合蛋白,将表达温度降低至18 A显着提高了所有融合蛋白的溶解度,MBP的溶解度,表达水平,易纯化性和易用性被选择用于进一步研究MBP-CCL2用常规色谱法纯化并用TEV或因子Xa蛋白酶裂解,荧光素酶和细胞迁移试验评估生物活性,发现因子Xa裂解的hCCL2具有活性,而TEV裂解的hCCL2活性相对较低TEV消化后,可能存在于hCCL2 N端的其他甘氨酸残基会干扰hCCL2与其受体的结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号